| Synonyms: | |
| Status: | Approved |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| UNII: | 8W1IQP3U10 |
| InChI Key | VTRAEEWXHOVJFV-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C24H26N6O3 |
| Molecular Weight | 446.51 |
| AlogP | 3.66 |
| Hydrogen Bond Acceptor | 7.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 8.0 |
| Polar Surface Area | 129.81 |
| Molecular species | ACID |
| Aromatic Rings | 4.0 |
| Heavy Atoms | 33.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| ANTAGONIST | Type-1 angiotensin II receptor antagonist | PubMed |
| Primary Target | |
|---|---|
| AT1 receptor |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Membrane receptor
Family A G protein-coupled receptor
Peptide receptor (family A GPCR)
Short peptide receptor (family A GPCR)
Angiotensin receptor
|
- | 8-8 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Hypertension | 3 | D006973 | ClinicalTrials |
| Atrial Fibrillation | 3 | D001281 | ClinicalTrials |
| Essential Hypertension | 3 | D000075222 | ClinicalTrials |
| Stroke | 2 | D020521 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 144689-24-7 |
| ChEBI | 48416 |
| ChEMBL | CHEMBL1516 |
| DrugBank | DB00275 |
| EPA CompTox | DTXSID2040571 |
| FDA SRS | 8W1IQP3U10 |
| Human Metabolome Database | HMDB0014420 |
| Guide to Pharmacology | 591 |
| PDB | OLM |
| PubChem | 158781 |
| SureChEMBL | SCHEMBL94037 |
| ZINC | ZINC000000538621 |